First Business Financial Services, Inc. Bristol Myers Squibb CO Transaction History

First Business Financial Services, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $33,936 - $40,495	-700 Reduced 14.9%	3,998 $205,000
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $7,525 - $8,414	130 Added 2.85%	4,698 $272,000
Q2 2023 Aug 07, 2023	SELL	$63.71 - $70.74 $15,927 - $17,685	-250 Reduced 5.19%	4,568 $292,000
Q4 2022 Feb 02, 2023	SELL	$68.48 - $81.09 $1,712 - $2,027	-25 Reduced 0.52%	4,818 $347,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $36 - $21,515	280 Added 6.14%	4,843 $344,000
Q2 2022 Aug 02, 2022	SELL	$72.62 - $79.98 $24,472 - $26,953	-337 Reduced 6.88%	4,563 $351,000
Q3 2021 Oct 26, 2021	BUY	$59.17 - $69.31 $11,834 - $13,862	200 Added 4.26%	4,900 $290,000
Q2 2021 Jul 20, 2021	BUY	$61.91 - $67.42 $290,977 - $316,874	4,700 New	4,700 $314,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of First Business Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on First Business Financial Services, Inc. with notifications on news.